BEAM
Beam Therapeutics Inc
24.50$
+0.5%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | 303,438.9% | 429,912.5% | 447.8% | 511.5% | 115.8% | 578.7% | 16.0% | |
| – | – | -303,338.9% | -429,812.5% | -347.8% | -411.5% | 100.0% | -478.7% | 84.0% | |
| – | – | 303,438.9% | 429,912.5% | 746.6% | 511.5% | 115.8% | 578.7% | 293.1% | |
| – | – | 114,183.3% | 123,354.2% | 110.4% | 144.1% | 30.9% | 175.6% | 81.4% | |
| – | – | 114,183.3% | 123,354.2% | 409.3% | 144.1% | 146.7% | 175.6% | 358.6% | |
| – | – | -417,522.2% | -553,166.7% | -757.0% | -555.6% | -46.7% | -654.3% | -274.6% | |
| – | – | 1,038.9% | 6,533.3% | 0.0% | 25.1% | 12.4% | 77.3% | 31.3% | |
| – | – | -435,144.4% | -810,800.0% | -714.9% | -468.9% | -34.7% | -593.1% | -57.2% | |
| – | – | 644.4% | 257,633.3% | -56.5% | 5.6% | 0.4% | 0.1% | – | |
| – | – | -435,144.4% | -810,800.0% | -714.9% | -474.5% | -35.1% | -593.1% | -57.2% | |
| – | – | -398,061.1% | -533,437.5% | -443.8% | -445.7% | -26.9% | -558.5% | -21.4% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.